Tryptophan metabolism through the kynurenine pathway is associated with endoscopic inflammation in ulcerative colitis

Mark (Anthony) Sofia, Matthew A. Ciorba, Katherine Meckel, Chai K. Lim, Gilles J. Guillemin, Christopher R. Weber, Marc Bissonnette, Joel R. Pekow

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background and Aims: Mucosal appearance on endoscopy is an important indicator of inflammatory burden and determines prognosis in ulcerative colitis (UC). Inflammation induces tryptophan metabolism along the kynurenine pathway (KP) and yields immunologically relevant metabolites. We sought to examine whether changes in serum tryptophan metabolites and tissue expression of KP enzymes are associated with UC endoscopic and histologic disease severity. Methods: Serum and mucosal samples were prospectively obtained at colonoscopy in patients with UC. Mayo disease activity scores, demographics, smoking status, medications, and outcomes were collected. Serum tryptophan metabolites were analyzed using ultra-high performance liquid chromatography (uHPLC), and gas chromatography-mass spectrometry (GC-MS), and enzyme expression was determined by quantitative real-time polymerase chain reaction. Metabolite and enzyme levels were compared by endoscopic subscore, clinical disease activity, time to surgery, and hospitalization. Results: This study included 99 patients with Mayo endoscopic subscores 0-3. Kynurenic acid/tryptophan ratio (KYNA/T) and expression of indolamine 2,3-dioxygenase 1 (IDO1), tryptophan 2,3-dioxygenase, kynurinase, and kynurenine monooxygenase correlated positively with endoscopic subscore. Adjusting for age of diagnosis, smoking status, disease extent, and medications yielded significant odds of endoscopic inflammation with increasing KYNA/T (OR 1.0015, P = 0.0186) and IDO1 expression (OR 1.0635, P = 0.0215). The highest tertile ratio of KYNA/T had shorter time to surgery (P = 0.009) and hospitalization (P = 0.01) than the lowest. Conclusions: Increasing KYNA/T is closely associated with endoscopic inflammation and predictive of disease outcomes in patients with UC. These findings identify this novel metabolic association and further support the role of the KP in regulating mucosal inflammation in UC.

Original languageEnglish (US)
Pages (from-to)1471-1480
Number of pages10
JournalInflammatory Bowel Diseases
Volume24
Issue number7
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Fingerprint

Kynurenine
Ulcerative Colitis
Tryptophan
Kynurenic Acid
Inflammation
Indoleamine-Pyrrole 2,3,-Dioxygenase
Hospitalization
Enzymes
Smoking
Serum
Tryptophan Oxygenase
Colonoscopy
Mixed Function Oxygenases
Gas Chromatography-Mass Spectrometry
Endoscopy
Real-Time Polymerase Chain Reaction
High Pressure Liquid Chromatography
Demography

Keywords

  • Mucosal healing
  • Tryptophan
  • Ulcerative colitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Gastroenterology

Cite this

Tryptophan metabolism through the kynurenine pathway is associated with endoscopic inflammation in ulcerative colitis. / Sofia, Mark (Anthony); Ciorba, Matthew A.; Meckel, Katherine; Lim, Chai K.; Guillemin, Gilles J.; Weber, Christopher R.; Bissonnette, Marc; Pekow, Joel R.

In: Inflammatory Bowel Diseases, Vol. 24, No. 7, 01.01.2018, p. 1471-1480.

Research output: Contribution to journalArticle

Sofia, MA, Ciorba, MA, Meckel, K, Lim, CK, Guillemin, GJ, Weber, CR, Bissonnette, M & Pekow, JR 2018, 'Tryptophan metabolism through the kynurenine pathway is associated with endoscopic inflammation in ulcerative colitis', Inflammatory Bowel Diseases, vol. 24, no. 7, pp. 1471-1480. https://doi.org/10.1093/ibd/izy103
Sofia, Mark (Anthony) ; Ciorba, Matthew A. ; Meckel, Katherine ; Lim, Chai K. ; Guillemin, Gilles J. ; Weber, Christopher R. ; Bissonnette, Marc ; Pekow, Joel R. / Tryptophan metabolism through the kynurenine pathway is associated with endoscopic inflammation in ulcerative colitis. In: Inflammatory Bowel Diseases. 2018 ; Vol. 24, No. 7. pp. 1471-1480.
@article{3fd07cbde3004864aa547e6a9b3eccc1,
title = "Tryptophan metabolism through the kynurenine pathway is associated with endoscopic inflammation in ulcerative colitis",
abstract = "Background and Aims: Mucosal appearance on endoscopy is an important indicator of inflammatory burden and determines prognosis in ulcerative colitis (UC). Inflammation induces tryptophan metabolism along the kynurenine pathway (KP) and yields immunologically relevant metabolites. We sought to examine whether changes in serum tryptophan metabolites and tissue expression of KP enzymes are associated with UC endoscopic and histologic disease severity. Methods: Serum and mucosal samples were prospectively obtained at colonoscopy in patients with UC. Mayo disease activity scores, demographics, smoking status, medications, and outcomes were collected. Serum tryptophan metabolites were analyzed using ultra-high performance liquid chromatography (uHPLC), and gas chromatography-mass spectrometry (GC-MS), and enzyme expression was determined by quantitative real-time polymerase chain reaction. Metabolite and enzyme levels were compared by endoscopic subscore, clinical disease activity, time to surgery, and hospitalization. Results: This study included 99 patients with Mayo endoscopic subscores 0-3. Kynurenic acid/tryptophan ratio (KYNA/T) and expression of indolamine 2,3-dioxygenase 1 (IDO1), tryptophan 2,3-dioxygenase, kynurinase, and kynurenine monooxygenase correlated positively with endoscopic subscore. Adjusting for age of diagnosis, smoking status, disease extent, and medications yielded significant odds of endoscopic inflammation with increasing KYNA/T (OR 1.0015, P = 0.0186) and IDO1 expression (OR 1.0635, P = 0.0215). The highest tertile ratio of KYNA/T had shorter time to surgery (P = 0.009) and hospitalization (P = 0.01) than the lowest. Conclusions: Increasing KYNA/T is closely associated with endoscopic inflammation and predictive of disease outcomes in patients with UC. These findings identify this novel metabolic association and further support the role of the KP in regulating mucosal inflammation in UC.",
keywords = "Mucosal healing, Tryptophan, Ulcerative colitis",
author = "Sofia, {Mark (Anthony)} and Ciorba, {Matthew A.} and Katherine Meckel and Lim, {Chai K.} and Guillemin, {Gilles J.} and Weber, {Christopher R.} and Marc Bissonnette and Pekow, {Joel R.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1093/ibd/izy103",
language = "English (US)",
volume = "24",
pages = "1471--1480",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Tryptophan metabolism through the kynurenine pathway is associated with endoscopic inflammation in ulcerative colitis

AU - Sofia, Mark (Anthony)

AU - Ciorba, Matthew A.

AU - Meckel, Katherine

AU - Lim, Chai K.

AU - Guillemin, Gilles J.

AU - Weber, Christopher R.

AU - Bissonnette, Marc

AU - Pekow, Joel R.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background and Aims: Mucosal appearance on endoscopy is an important indicator of inflammatory burden and determines prognosis in ulcerative colitis (UC). Inflammation induces tryptophan metabolism along the kynurenine pathway (KP) and yields immunologically relevant metabolites. We sought to examine whether changes in serum tryptophan metabolites and tissue expression of KP enzymes are associated with UC endoscopic and histologic disease severity. Methods: Serum and mucosal samples were prospectively obtained at colonoscopy in patients with UC. Mayo disease activity scores, demographics, smoking status, medications, and outcomes were collected. Serum tryptophan metabolites were analyzed using ultra-high performance liquid chromatography (uHPLC), and gas chromatography-mass spectrometry (GC-MS), and enzyme expression was determined by quantitative real-time polymerase chain reaction. Metabolite and enzyme levels were compared by endoscopic subscore, clinical disease activity, time to surgery, and hospitalization. Results: This study included 99 patients with Mayo endoscopic subscores 0-3. Kynurenic acid/tryptophan ratio (KYNA/T) and expression of indolamine 2,3-dioxygenase 1 (IDO1), tryptophan 2,3-dioxygenase, kynurinase, and kynurenine monooxygenase correlated positively with endoscopic subscore. Adjusting for age of diagnosis, smoking status, disease extent, and medications yielded significant odds of endoscopic inflammation with increasing KYNA/T (OR 1.0015, P = 0.0186) and IDO1 expression (OR 1.0635, P = 0.0215). The highest tertile ratio of KYNA/T had shorter time to surgery (P = 0.009) and hospitalization (P = 0.01) than the lowest. Conclusions: Increasing KYNA/T is closely associated with endoscopic inflammation and predictive of disease outcomes in patients with UC. These findings identify this novel metabolic association and further support the role of the KP in regulating mucosal inflammation in UC.

AB - Background and Aims: Mucosal appearance on endoscopy is an important indicator of inflammatory burden and determines prognosis in ulcerative colitis (UC). Inflammation induces tryptophan metabolism along the kynurenine pathway (KP) and yields immunologically relevant metabolites. We sought to examine whether changes in serum tryptophan metabolites and tissue expression of KP enzymes are associated with UC endoscopic and histologic disease severity. Methods: Serum and mucosal samples were prospectively obtained at colonoscopy in patients with UC. Mayo disease activity scores, demographics, smoking status, medications, and outcomes were collected. Serum tryptophan metabolites were analyzed using ultra-high performance liquid chromatography (uHPLC), and gas chromatography-mass spectrometry (GC-MS), and enzyme expression was determined by quantitative real-time polymerase chain reaction. Metabolite and enzyme levels were compared by endoscopic subscore, clinical disease activity, time to surgery, and hospitalization. Results: This study included 99 patients with Mayo endoscopic subscores 0-3. Kynurenic acid/tryptophan ratio (KYNA/T) and expression of indolamine 2,3-dioxygenase 1 (IDO1), tryptophan 2,3-dioxygenase, kynurinase, and kynurenine monooxygenase correlated positively with endoscopic subscore. Adjusting for age of diagnosis, smoking status, disease extent, and medications yielded significant odds of endoscopic inflammation with increasing KYNA/T (OR 1.0015, P = 0.0186) and IDO1 expression (OR 1.0635, P = 0.0215). The highest tertile ratio of KYNA/T had shorter time to surgery (P = 0.009) and hospitalization (P = 0.01) than the lowest. Conclusions: Increasing KYNA/T is closely associated with endoscopic inflammation and predictive of disease outcomes in patients with UC. These findings identify this novel metabolic association and further support the role of the KP in regulating mucosal inflammation in UC.

KW - Mucosal healing

KW - Tryptophan

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=85054204708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054204708&partnerID=8YFLogxK

U2 - 10.1093/ibd/izy103

DO - 10.1093/ibd/izy103

M3 - Article

C2 - 29796641

AN - SCOPUS:85054204708

VL - 24

SP - 1471

EP - 1480

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 7

ER -